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Abstract
Currently, there are single data on the relationship between TLR-2 polymorphisms (Arg753Gln) and TLR-4 (Asp299Gly) poly-
morphisms and susceptibility to brucellosis. Therefore, the aim of the study was to determine the frequency of TLR-2 (Arg753Gln) 
and TLR-4 (Asp299Gly) polymorphisms in patients with acute brucellosis with cardiovascular lesions in the Republic of Azerbaijan. 
Materials and methods: 178 patients with a brucellosis clinic were examined. According to the criteria for inclusion in the 
study, only 120 people fully met all the criteria, which made up the main group. The control group consisted of 30 healthy individuals. 
TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly) polymorphisms were also determined for all patients in both groups. In order to assess 
the state of the cardiovascular system, an electrocardiogram was recorded, blood pressure was measured, and an ultrasound scan of the 
heart was performed for all patients. 
Results: it was found that 93 patients (77.50±3.13 %) with acute brucellosis had some or other signs of impairment in the work 
of the cardiovascular system, identified clinically or as a result of functional examination. Among carriers of the Asp/Gly genotype of 
the TLR-4 gene, an increased risk of brucellosis with CVS diseases was determined (χ2=30.19; p<0.0001; OR=24.29; 95 % CI [5.45 – 
108.37]), while the carriage of the homozygous genotype Asp/Asp, by contrast, had a protective effect on the development of brucellosis 
(OR=0.06, 95 % CI [0.02 – 0.20]). Among the carriers of the Arg/Gln genotype and the Gln/Gln genotype of the TLR-2 gene, a signifi-
cantly increased risk of brucellosis with CVS diseases was determined (χ2=5.68; p=0.02; OR=3.10; 95 % CI [0.99–9.67]) and (OR=2.48; 
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95 % CI [0.53–11.61]), respectively. While the carriage of the homozygous Arg/Arg genotype, by contrast, was rarely seen in patients 
with brucellosis (OR=0.28, 95 % CI [0.10–0.74]).
Conclusions: The Asp/Gly genotype of the TLR-4 gene was 12.7 times more frequently detected in patients with acute bru-
cellosis with CVS diseases than in healthy individuals and 9.5 times more often than in patients without CVS diseases (p<0.05). The 
Arg/Gln genotype of the TLR-2 gene was 2.4 times more frequently detected in patients with acute brucellosis with CVS diseases than 
in healthy individuals (p<0.05).
Keywords: acute brucellosis, TLR-4, TLR-2, polymorphism, cardiovascular system.
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1. Introduction
Brucellosis is one of the most common zoonotic infections in the world, annually there are 
about 500 thousand new cases [1, 2]. Despite the wide spread of this infection in the world, there are 
areas with a pronounced endemic for brucellosis. These territories include the Republic of Azerbai-
jan, where new cases of brucellosis are recorded annually [3, 4].
An important social aspect of brucellosis is the high proportion among people with brucello-
sis - children and adolescents, people of young working age, as well as involvement in the epidemic 
process of people who are not professionally associated with the source of possible infection [5, 6]. 
The disease occurs with the affection of all organs and systems, which leads to the development of 
extremely adverse effects: loss of working ability and disability of patients, which determines its 
high socio-economic significance [7, 8]. According to different data, complications of the cardio-
vascular system in patients with brucellosis occur in less than 2–10 % of patients. The endocardium 
is most often affected [9, 10].
It is known that the first line of protection of the body against infectious agents, including 
Brucella, is the innate immunity system [11, 12]. Microbial detection using Toll-like receptors 
(TLR) is one of the decisive steps in the activation of the innate immune response and is important 
for the reliable initiation of the adaptive immune response [13, 14]. Recent studies have shown that 
both members of the TLR family (TLR2 and TLR4) recognize components of different pathogens. 
Thus, TLR-2 interacts predominantly with lipoproteins of gram-positive bacteria, whereas TLR-4 
interacts with lipopolysaccharide of gram-negative bacteria [15, 16].
To date, the study of the polymorphism of the genes of inflammatory regulatory molecules 
is of particular relevance. Determining their role in the pathogenesis of many diseases, including 
brucellosis, together with the achievements of modern genomics, allows us to predict the risk of 
developing the pathology or the severity of its course, on the other hand, to personify pharma-
cotherapy.
2. Aim of the research
Determine the frequency of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly) polymorphisms in 
patients with acute brucellosis with cardiovascular lesions in the Republic of Azerbaijan.
3. Materials and methods
We examined 178 patients with brucellosis who sought medical care at the Baku Clinic and 
the Central Clinical Hospital of Baku. All patients gave permission for their inclusion in the study.
The diagnosis of acute brucellosis was established on the basis of clinical data, anamnesis, 
including epidemiological, objective examination data, results of laboratory diagnostics, including 
specific ones.
Specific research methods were performed by ELISA on Awareness and Stat Fax 3200 de-
vices using NovaLisa Brusella IgG, IgM test systems (Germany) with the detection of IgM and IgG.
The criteria for inclusion in the study was the diagnosis of acute brucellosis, while taking 
into account the duration of the clinical symptoms, namely up to 3 months after the first com-
plaints appeared.
According to the criteria for inclusion in the study, out of 178 patients examined, only 120 people 
fully met all the criteria, which made up the main group. The control group consisted of 30 healthy 
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individuals who underwent a scheduled annual inspection. Groups were representative by age and 
sex. Patients of both groups are ethnic Azerbaijanis who permanently reside in the Republic of 
Azerbaijan. The average age of patients in the main group was 35.9±2.8 years. Male subjects were 
predominant – 75.00 %.
In order to assess the state of the cardiovascular system (CVS), all patients were regis-
tered with an electrocardiogram (ECG) according to the standard technique in 12 standard leads. 
Measurement of blood pressure (BP) was carried out according to the recommendations of WHO 
experts (2014). To assess the parameters of systemic and intracardiac hemodynamics, ultrasound 
test (EchoCG) of the heart was used using standard accesses for examination and analysis of the 
necessary indicators of the structural and functional state of the heart (as recommended by the 
European Society of Cardiology, 2016).
All patients were determined polymorphism (Arg753Gln) TLR-2. The DNA amplifi-
cations of the studied loci were carried out automatically using the following primer structure: 
F: 5′-GAGTGGTGCAAGTATGAACTGGA-3′, R: 5′-TCCCAACTAGACAAAGACTGGTCT-3′. After 
initial denaturation at 94 °C for 5 minutes, each stage was carried out in 3 stages: denaturation – 
94 °C (30 s), annealing of primers (30–45 s), elongation – 72 °C (30–40 s). The final elongation last-
ed 10 minutes at 72 °C. To identify the alleles of the TLR-2 gene, restriction analysis of amplicons 
was performed using the Pst I restriction endonuclease (NPO 56) and restriction was performed for 
12 hours at 37 °C. The products of hydrolysis of the amplified sequences were analyzed by electro-
phoresis in 2 % agarose gel.
TLR-4 polymorphism (Asp299Gly) was also determined for all patients in both groups. 
Genomic DNA was isolated from peripheral venous blood, which was collected from the cubi-
tal vein into sterile vacutainers with stabilizer 44 (EDTA) using the “DNA / RNA isolation kit 
from serum or blood plasma” (NPF “LiTech”, Russia). The Asp299Gly polymorphism TLR-4 
was amplified by PCR using specific oligonucleotide primers. Amplifications were performed 
on a Tertsik amplificator (DNATechnology, Moscow). The 25 µl PCR mix contained 2.5 µl of 
10x amplification buffer; 2 mM magnesium chloride; 0.2 mmol of each dNTP; 66 ng specific 
primers; 2.5 units Act. Taq DNA polymerase (SibEnzyme, Russia); 20-50 ng of genomic DNA. 
25 µl of mineral oil was layered into tubes. Annealing temperature for determining the Asp-
299Gly TLR-4 polymorphism site is 58 °C. TLR4 gene alleles were identified by restriction 
analysis of amplicons using the restriction endonuclease Bsp19 (SibEnzyme, Russia) at 37 °C. 
Cleavage products of the polymorphic portion of TLR4 genes were detected by electrophoresis 
in 3 % agarose gel in 1 x TBE buffer (for 2 hours) at a voltage of 2V per 1 cm of gel). PBR322/
BsuRI was used as a DNA molecular weight marker. Gels were stained with ethidium bromide 
followed by visualization of the results in UV light.
The significance of differences in the distribution of genotypes in polymorphic loci between 
groups was checked for compliance with the Hardy-Weinberg equilibrium (http://gen-exp.ru/ 
calculator_or.php).
Statistical processing of the research results was performed using the IBM SPSS Statistics 
program, version 12 (20) (licensed No. 9593869, belongs to the Department of Infectious Diseases 
with a course of epidemiology at the Vinnytsia National Medical University named after NI Piro-
gov of the Ministry of Health of Ukraine) using parametric and non-parametric assessment meth-
ods obtained results. The calculation of the arithmetic average value (M) and standard error of the 
indicator (m) was carried out. When assessing quality indicators, the frequency of occurrence (%) 
and its standard error (m %) were calculated.
Comparison of the frequencies of genotypes and alleles was performed by analyzing the 
contingency tables using Fisher’s exact test and χ2 test, depending on the assumptions of the anal-
ysis. The risk of developing pathology was assessed by calculating the odds ratio (OR) with the 
95 % confidence interval (CI) determined using simple logistic regression.
4. Results
The study found that 93 patients (77.50±3.13 %) with acute brucellosis had some or other 
signs of CVS malfunctioning that were identified clinically or as a result of a functional examina-
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tion. Such a number of patients with changes in CVS, in our opinion, may be due not only to the 
direct action of the infectious agent, but also to the previously existing CVS lesion.
The most frequent clinical manifestations of CVS lesions were: weakening of heart sounds 
(in 45.83±3.73 % of patients), hypotension (in 40.83±3.68 % of people) and non-ischemic cardialgia 
(in 36.67±3.61 % of patients).
An analysis of ECG data in 12 derivations found that the overwhelming majority of pathol-
ogies concerned automatism disorders (in 67.54±3.51 % of patients) and ventricular repolarization 
processes (in 31.65±3.49 % of people). Moreover, among the disorders of automatism, the tendency 
to tachycardia dominated, the conduction disturbances were expressed mainly by the slowing down 
of impulse conduction along the bundle of His, and the excitability disturbances – mainly by the 
appearance of ventricular extrasystoles.
The data of echocardiographic examination of patients with acute brucellosis were also 
analyzed. In general, the average indicators of the structure and function of the heart in the group 
of patients with acute brucellosis, according to EchoCG, did not go beyond the framework of the 
corresponding generally accepted norms. However, the average values of individual indicators 
differed significantly from those in the control group. So in patients with acute brucellosis com-
pared with the control group, an increase in heart rate was observed by 11.94 % (p<0.05), while 
the diastolic blood pressure was 18.77 % lower (p<0.01). The level of systolic pressure in the 
main group was not significantly different from the control group. Also in patients with brucello-
sis, significant differences in the size and volume of the left ventricle were found. Diastolic size 
and volume of the left ventricle in the main group, respectively, by 11.91 % and 8.33 % exceed 
those in the control group (p<0.05). The size of the left atrium in the main group is 9.51 % higher 
than the corresponding figure in the group of practically healthy individuals (p<0.05). It has been 
established that the state of the systolic and diastolic functions of the left ventricle in patients 
with acute brucellosis varies significantly. The main indicator of the systolic function of the left 
ventricle, namely the ejection fraction, is 6.90 % lower in the main group of the study than in the 
control group (p<0.05). However, a moderate decrease in left ventricular systolic function was 
recorded only in 6 patients (5.51 %).
It was found that the Asp/Gly genotype of the TLR-4 gene was 12.7 times more frequent 
in patients with acute brucellosis with CVS than in healthy individuals and 9.5 times more often 
than in patients without CVS (p<0, 05). Whereas, the Asp/Asp genotype was more often detected 
in healthy individuals. The mutant Gly allele was significantly more often, 5.2 times more common 
among patients with brucellosis with CVS lesion than among healthy individuals and 6.4 times 
more often than among patients with brucellosis without CVS lesion (p<0.05) (Table 1).
Table 1
The detection rate of polymorphism (Asp299Gly) of the TLR-4 gene in patients with brucellosis with and 
without CVS lesion
Genotypes and alleles 
TLR-4 (Asp299Gly)
Patients with brucellosis with-
out CVS lesions (n=27)
Patients with brucellosis with 
CVS lesions (n=93)
Healthy persons  
(n=30)
Abs. % Abs. % Abs. %
Genotype Asp/Asp 4 14.8±6.83* 31 33.3±4.88* 27 90.0±5.48
Genotype Asp/Gly 23 85.2±6.84* 59 63.5±4.99* 2 6.7±4.56
Genotype Gly/Gly 0 0 3 3.2±1.83 1 3.3±1.81
Allele Asp 31 57.4±9.52 121 65.1±4.94 56 93.3±4.56 
Allele Gly 23 42.6±9.52* 65 34.9±4.94* 4 6.7±2.14
Note: * – р<0.05 – between patients with brucellosis with and without CVS diseases, and healthy individuals
It was found that the Arg/Gln genotype of the TLR-2 gene was 2.4 times more frequently 
detected in patients with acute brucellosis with CVS lesion than in healthy individuals (p<0.05). 
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Whereas, the Arg/Arg genotype was more frequently detected in healthy individuals. The mutant 
Gln allele, significantly more often, 2.3 times was found among patients with brucellosis with CVS 
lesion than among healthy individuals (p<0.05). Significant differences between the frequency of 
detection of polymorphism (Arg753Gln) of the TLR-2 gene in patients with brucellosis without 
CVS lesions and practically healthy individuals were not identified (Table 2).
Table 2
The frequency of detection of polymorphism (Arg753Gln) of the TLR-2 gene in patients with brucellosis with 
and without CVS lesions
Genotypes and alleles 
TLR-2 (Arg753Gln)
Patients with brucellosis with-
out CVS lesions (n=27)
Patients with brucellosis with 
CVS lesions (n=93)
Healthy persons  
(n=30)
Abs. % Abs. % Abs. %
Genotype Asp/Asp 20 74.1±8.43 49 52.7±5.18* 24 80.0±7.3
Genotype Asp/Gly 4 14.8±6.83 30 32.3±4.85* 4 13.3±6.19
Genotype Gly/Gly 3 11.1±6.05 14 15.0±3.7* 2 6.7±2.96
Allele Asp 44 81.5±7.47 128 68.8±4.8 52 86.7±6.19
Allele Gly 10 18.5±7.47 58 31.2±4.8* 8 13.3±6.19
Note: * – р<0.05 – between patients with brucellosis with and without CVS lesions, and healthy individuals
The next step in our study was to establish the risks of brucellosis with CVS lesions, taking 
into account the carriage of polymorphic variants of the TLR-4 and TLR-2 genes. When studying 
the features of the distribution of allele frequency in patients with brucellosis, it was found that 
carriers of the Gly allele of the polymorphic (Asp299Gly) TLR-4 gene have an increased risk of 
developing brucellosis with CVS lesions (OR=7.52, 95 % CI [2.61–21.67]), then as in the case of 
carriage of the Asp allele, on the contrary, the risk of developing brucellosis is reduced (OR=0.13, 
95 % CI [0.05–0.38]); the model is reliable at χ2=17.98, p<0.0001 (Table 3).
We found that among carriers of the Asp/Gly genotype, a significantly increased risk of bru-
cellosis with CVS lesions (χ2=30.19; p<0.0001; OR=24.29; 95 % CI [5.45–108.37]) was determined, 
whereas the carrier state is homozygous the Asp / Asp genotype, in contrast, had a protective effect 
on the development of brucellosis (OR=0.06, 95 % CI [0.02–0.20]).
Table 3
Association of alleles and genotypes for polymorphism (Asp299Gly) of the TLR-4 gene with susceptibility 
to brucellosis with CVS lesions
Genotypes and alleles
Patients with brucel-
losis with CVS lesions 
(n=93)




sign. 95 % CI
Allele Asp 0.651 0.933
17.98 <0,0001
0.13 0.05–0.38
Allele Gly 0.349 0.067 7.52 2.61–21.67
Genotype Asp/Asp 0.333 0.900
30.19 <0,0001
0.06 0.02–0.20
Genotype Asp/Gly 0.634 0.067 24.29 5.45–108.37
Genotype Gly/Gly 0.032 0.033 0.97 0.10–9.66
When studying the characteristics of the distribution of allele frequency in patients with 
brucellosis, it has been found that carriers of the Gln allele of the polymorphic (Arg753Gln) TLR-2 
gene have an increased risk of developing brucellosis with CVS (OR=2.95, 95 % CI [1.31–6.60]), 
model reliable at χ2=7.36, p=0.007 (Table 4).
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We found that among patients with brucellosis with CVS and practically healthy individu-
als, the frequency of the heterozygous genotype Arg/Gln (Arg753Gln) of the TLR-2 gene was 0.323 
and 0.133, respectively. That is, among carriers of this genotype, a significantly increased risk of 
brucellosis with CVS (χ2=5.68; p=0.02; OR=3.10; 95 % CI [0.99–9.67]) was determined, while the 
homozygous genotype Arg/Arg, on the contrary, it had a protective effect on the development of 
brucellosis (OR=0.28, 95 % CI [0.10–0.74]). It was also found that carriers of the mutant homozy-
gous genotype Gln/Gln also had an increased risk of developing acute brucellosis with CVS lesions 
(χ2=5.68; p=0.02; OR=2.48; 95 % CI [0.53–11.61]).
Table 4
Association of alleles and genotypes for polymorphism (Arg753Gln) of the TLR-2 gene with susceptibility to 
brucellosis with CVS lesion
Genotypes and alleles
Patients with brucel-
losis with CVS lesions 
(n=93)




sign. 95 % CI
Allele Asp 0.688 0.867
7.36 0.007
0.34 0.15–0.76
Allele Gly 0.312 0.133 2.95 1.31–6.60
Genotype Asp/Asp 0.527 0.800
5.68 0.02
0.28 0.10–0.74
Genotype Asp/Gly 0.323 0.133 3.10 0.99–9.67
Genotype Gly/Gly 0.151 0.067 2.48 0.53–11.61
5. Discussion
The role of TLR-4 polymorphism and its relationship with brucellosis is an ambiguous 
and poorly understood problem. At the moment, in the available scientific literature, there are 
single data, as in one study, the polymorphism (Asp299Gly) of the TLR-4 gene was analyzed in 
patients with brucellosis. Based on the analysis of which, the researchers concluded that the Gly 
allele was more common among patients with brucellosis compared with healthy individuals 
(33.6 % versus 20.7 %, p=0.000003). That is, this study first revealed the link between the genetic 
polymorphism of the TLR4 gene and susceptibility to brucellosis [17]. As for the role of TLR-2 
polymorphism and its relationship with brucellosis, at the moment there is only data relating to 
TLR-2 polymorphism and various diseases caused by infectious agents. So, it was found that the 
TLR2 polymorphism was associated with septic shock [18]. A link was also found with tubercu-
losis, rheumatic fever [19, 20].
Considering the small number of works devoted to the role of TLR-2 and TLR-4 polymor-
phism among patients with brucellosis, and especially certain groups with CVS lesions, of the 
hepatobiliary systems. In our opinion, an important aspect is a more thorough study of the state of 
the cardiovascular system with the obligatory use of instrumental methods of examination with the 
aim of early detection of signs of damage, timely involvement of appropriate therapeutic measures, 
as well as with the study of genetically determined risk factors for the development of these com-
plications among patients with brucellosis.
6. Conclusions
1. The most frequent clinical manifestations of CVS lesions were: weakening of heart tones 
(in 45.83±3.73 % of patients), hypotension (in 40.83±3.68 % of people) and non-ischemic cardialgia 
(in 36.67±3, 61 % of patients).
2. The Asp/Gly genotype of the TLR-4 gene was 12.7 times more frequent in patients with 
acute brucellosis with CVS lesions than in healthy individuals and 9.5 times more often than in 
patients without CVS lesions (p<0.05) .
3. The Arg/Gln genotype of the TLR-2 gene was 2.4 times more frequently detected in pa-
tients with acute brucellosis with CVS lesions than in healthy individuals (p<0.05).
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4. Among carriers of the Asp/Gly genotype of the TLR-4 gene, an increased risk of brucel-
losis with CVS lesions (χ2=30.19; p <0.0001; OR=24.29; 95 % CI [5.45–108.37]) was determined, 
while the carriage the homozygous genotype Asp/Asp, on the contrary, had a protective effect on 
the development of brucellosis (OR=0.06, 95 % CI [0.02 – 0.20]).
5. Among the carriers of the Arg/Gln genotype and the Gln/Gln genotype of the TLR-2 
gene, a significantly increased risk of brucellosis with CVS lesions was determined (χ2=5.68; p=0.02; 
OR=3.10; 95 % CI [0.99–9.67]) and (OR=2.48; 95 % CI [0.53–11.61]), respectively. While the car-
riage of the homozygous Arg / Arg genotype, on the contrary, had a protective effect on the devel-
opment of brucellosis (OR=0.28, 95 % CI [0.10–0.74]).
References
[1] Najafi, N., Davoudi, A., Hassantabar, S. R., Haddadi, R. (2018). Investigating the Epidemiologic, Laboratory, and Clinical 
Features of Brucellosis Patients Hospitalized in the North of Iran During 2009–2014. Archives of Clinical Infectious Diseases, 
13 (2). doi: http://doi.org/10.5812/archcid.61012 
[2] Mugahi, S., Nashibi, R., Alavi, S. M., Gharkholu, S., Najafi, K. (2014). Epidemiological Features, Clinical Manifestation and 
Laboratory Findings of Patients With Brucellosis. Archives of Clinical Infectious Diseases, 9 (1). doi: http://doi.org/10.5812/
archcid.17270 
[3] Nourbakhsh, F., Borooni, S., Barangi, S., Tajbakhsh, E. (2017). Diagnosis of clinical and laboratory findings of brucellosis in 
Isfahan. International Archives of Health Sciences, 4 (2), 48. doi: http://doi.org/10.4103/iahs.iahs_1_17 
[4] Garcell, H. G., Garcia, E. G., Pueyo, P. V., Martín, I. R., Arias, A. V., Alfonso Serrano, R. N. (2016). Outbreaks of brucellosis 
related to the consumption of unpasteurized camel milk. Journal of Infection and Public Health, 9 (4), 523–527. doi: http:// 
doi.org/10.1016/j.jiph.2015.12.006 
[5] Kazak, E., Akalın, H., Yılmaz, E., Heper, Y., Mıstık, R., Sınırtaş, M. et. al. (2016). Brucellosis: a retrospective evaluation of 
164 cases. Singapore Medical Journal, 57 (11), 624–629. doi: http://doi.org/10.11622/smedj.2015163 
[6] Bukharie, H. A. (2009). Clinical features, complications and treatment outcome of Brucella infection: Ten years’ experience in 
an endemic area. Tropical Journal of Pharmaceutical Research, 8 (4). doi: http://doi.org/10.4314/tjpr.v8i4.45221 
[7] Nassaji, M., Govhary, A., Ghorbani, R. (2015). Epidemiological, clinical and laboratory findings in adult patients with acute 
brucellosis: A case-control study. Acta Medica Mediterranea, 1319–1325. Available at: http://eprints.semums.ac.ir/id/eprint/78
[8] Sofian, M., Aghakhani, A., Velayati, A. A., Banifazl, M., Eslamifar, A., Ramezani, A. (2008). Risk factors for human bru-
cellosis in Iran: a case–control study. International Journal of Infectious Diseases, 12 (2), 157–161. doi: http://doi.org/10.1016/ 
j.ijid.2007.04.019 
[9] Lagadinou, M., Mplani, V., Velissaris, D., Davlouros, P., Marangos, M. (2019). Myocarditis Caused by Brucella melitensis 
in the Absence of Endocarditis: Case Report and Review of the Literature. Case Reports in Medicine, 2019, 1–4. doi: http:// 
doi.org/10.1155/2019/3701016 
[10] Pandit, V. R., Seshadri, S., Valsalan, R., Bahuleyan, S., Vandana, K. E., Kori, P. (2010). Acute brucellosis complicated by fatal 
myocarditis. International Journal of Infectious Diseases, 14 (4), e358–e360. doi:  http://doi.org/10.1016/j.ijid.2009.05.013 
[11] Yurko, K. V. (2015). Prevalence of TLR-4 gene polymorphism in patients co-infected with HIV/HCV. ScienceRise, 11 (3 (16)), 
86–89. doi: http://doi.org/10.15587/2313-8416.2015.54495 
[12] Cai, Y., Peng, Y.-H., Tang, Z., Guo, X.-L., Qing, Y.-F., Liang, S.-H. et. al. (2014). Association of Toll-like receptor 2 polymor-
phisms with gout. Biomedical Reports, 2 (2), 292–296. doi: http://doi.org/10.3892/br.2014.224 
[13] Kawai, T., Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature 
Immunology, 11 (5), 373–384. doi: http://doi.org/10.1038/ni.1863 
[14] Tongtawee, T., Bartpho, T., Kaewpitoon, S., Kaewpitoon, N., Dechsukhum, C., Leeanansaksiri, W. et. al. (2018). Genetic 
polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis. European Journal of Cancer 
Prevention, 27 (2), 118–123. doi: http://doi.org/10.1097/cej.0000000000000347 
[15] Ferrero, M. C., Hielpos, M. S., Carvalho, N. B., Barrionuevo, P., Corsetti, P. P., Giambartolomei, G. H. et. al. (2013). Key Role of 
Toll-Like Receptor 2 in the Inflammatory Response and Major Histocompatibility Complex Class II Downregulation in Brucella 
abortus-Infected Alveolar Macrophages. Infection and Immunity, 82 (2), 626–639. doi: http://doi.org/10.1128/iai.01237-13 
[16] Oliveira, S. C., de Oliveira, F. S., Macedo, G. C., de Almeida, L. A., Carvalho, N. B. (2008). The role of innate immune recep-
tors in the control of Brucella abortus infection: Toll-like receptors and beyond. Microbes and Infection, 10 (9), 1005–1009. 
doi: http://doi.org/10.1016/j.micinf.2008.07.005 
[17] Rezazadeh, M., Hajilooi, M., Rafiei, A., Haidari, M., Nikoopour, E., Kerammat, F. et. al. (2006). TLR4 polymorphism in Irani-
an patients with brucellosis. Journal of Infection, 53 (3), 206–210. doi: http://doi.org/10.1016/j.jinf.2005.10.018 
Original Research Article:
full paper




[18] Nguyen, M.-T., Peisl, L., Barletta, F., Luqman, A., Götz, F. (2018). Toll-Like Receptor 2 and Lipoprotein-Like Lipoproteins 
Enhance Staphylococcus aureus Invasion in Epithelial Cells. Infection and Immunity, 86 (8). doi: http://doi.org/10.1128/
iai.00627-18 
[19] Xue, X., Qiu, Y., Jiang, D., Jin, T., Yan, M., Zhu, X., Chu, Y. (2017). The association analysis of TLR2 and TLR4 gene with 
tuberculosis in the Tibetan Chinese population. Oncotarget, 8 (68). doi: http://doi.org/10.18632/oncotarget.22996 
[20] Zhao, J., Shang, H., Cao, X., Huang, Y., Fang, X., Zhang, S. et. al. (2017). Association of polymorphisms in TLR2 and TLR4 
with asthma risk. Medicine, 96 (35), e7909. doi: http://doi.org/10.1097/md.0000000000007909 
USE OF PLATELETS RICH PLASMA AS A FACTOR OF THE 
REDUCTION OF THE RISK OF EARLY POSTOPERATIVE 
COMPLICATIONS IN PATIENTS WITH POSTOPERATIVE 
VENTRAL HERNIAS
Dmitry Atanasov 
Department of Surgery No. 4 with a course of oncology
Center for Reconstructive and Restorative Medicine (University Clinic)
Odessa National Medical University
2 Valihovsky ave., Odessa, Ukraine, 65082
dmitriyatanasov@gmail.com 
Abstract
Non-tensioned allohernioplasty with a polypropylene mesh implant has several disadvantages associated with the local oc-
currence of non-specific long-lasting inflammatory reactions in response to a foreign body. Excessive exudation in the implantation 
zone leads to the formation of seromas, requiring puncture aspiration, which significantly increases the treatment time. In the long-
term, chronic prolonged inflammatory process leads to the formation of coarse connective tissue, which explains the development 
of biomechanical complications. Growth factors, introduced by platelet rich plasma (PRP), stimulate the release of regenerative cy-
tokines, reduce local inflammatory manifestations in the integration of homoplastic grafts and reduce the incidence of postoperative 
complications.
Aim: through the use of plasma enriched with platelets reduce the severity of early postoperative complications in patients 
with postoperative ventral hernias. 
Materials and methods. A clinical study was performed in the surgical department of the center for reconstructive and 
restorative medicine (university clinic) of the Odessa National Medical University (ONMedU) in the period from 2013 to 2019: 
84 patients were operated because of postoperative ventral hernia. The average age of patients was 60.1±7.6 years. The size of hernial 
defects was on average 8.2 cm. The average BMI was 31.8 kg/m2. According to indications, patients underwent a standard surgical 
extent of intervention: hernia repair, allohernioplasty of the anterior abdominal wall with a lightweight (80 g/m2) polypropylene im-
plant. After the plastics of the main group, a prosthesis implantation zone was infiltrated with activated autologous PRP, which was 
prepared by double centrifugation, in a volume of 14–38 ml. There was a control group in which PRP infiltration was not performed. 
The cavity above the mesh implant was actively drained by Redon for 2–4 days. An ultrasound examination was performed and, if 
necessary, fine needle aspiration of serous fluid over the mesh was done.
Results. The evaluation of the postoperative period (up to 28 days) in patients of both groups. In none of the cases were 
manifestations of allergic, pyrogenic, local inflammatory or infectious complications. According to the quantitative assessment of 
early postoperative complications as well as the assessment of the degree of pain syndrome subjectively, according to VAS, the post-
operative period in the main and control study groups was almost identical. The need for puncture aspirations and the total volume of 
discharge was significantly less in the main study group. The dependence of the severity of the effect of the proposed technology on 
such factors as the size of the hernial defect, the nature of plastics, and body mass index was noted. The greatest efficacy was demon-
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